Condition
Location
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Cookies & Data Use Policy
At Power, we believe in using data responsibly to help you find the right clinical trials — without compromising your privacy. This page explains how we use cookies and personal data across www.withpower.com.
When you browse Power's website, you're opting in to our use of cookies. Cookies are used to improve your experience and help us understand how the site is used so that we can make improvements for you in the future. Specifically, we use cookies to:
We use cookies to customize your visit based on basic information like your general location (determined by your IP address). This allows us to:
We remember what you interact with during your visit — for example:
This helps us make your experience more efficient and personalized the next time you visit.
Cookies help us collect anonymous usage data so we can make Power better. We use these insights to:
These analytics are aggregated and do not include personal identifiers. We use tools like Google Analytics to process this data, but we don't use it to target ads or sell your information.
We do not:
All cookie use is designed to support your experience on Power — never to track you across the internet or monetize your information.
When you sign up for a Power account, you agree to our Privacy Policy and Terms of Service. Creating a profile allows us to better serve you by tailoring the platform to your specific needs.
Once you create a profile:
We use your data solely to fulfill our mission: helping you find clinical trials that could be a fit — not for advertising or resale.
Search Clinical Trials
Conditions
Locations
Treatment Type
Trial Phase
Trial Status
Paid Participation
No results match your current search. Try removing one or more filters below, or updating your condition to see more clinical trials.
Know someone looking for new options?
Spread the word
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Social Anxiety trials 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length for Social Anxiety is 12 months.
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
New clinical trials are added to our platform regularly.
Yes—most people can greatly reduce or even “beat” social anxiety once they use the right tools. The best-proven approach is cognitive-behavioural therapy that teaches realistic thinking and gradual practice in feared situations; if symptoms remain severe, adding an SSRI-type medication or combining the two boosts success rates. Start by booking an appointment with a CBT-trained mental-health professional (or a guided online CBT program) and, if needed, discuss medication options with your doctor—evidence shows that following this plan helps the majority of people reclaim their social life.
The 3 C’s drawn from cognitive-behavioural therapy are: Catch the anxious thought as soon as it pops up, Check whether it is completely true or helpful, and Change it to a more balanced statement or calming action. Running through this quick three-step loop interrupts the worry spiral and trains your brain to think in a more realistic, less fearful way. If anxiety keeps disrupting your life, a therapist can guide you in practising the 3 C’s more effectively.
Research shows the strongest link to later social anxiety comes from emotional abuse or neglect—situations where a child is constantly ridiculed, shamed, or ignored—but the risk also rises after chronic bullying, highly critical or over-controlling parenting, and, though less specifically, physical or sexual abuse. These experiences teach the child that people are dangerous and that they themselves don’t measure up, wiring the brain to expect rejection; yet plenty of children with such histories avoid social anxiety when they receive warmth and skilled help early on.
A lasting wish to keep away from others is generally called social withdrawal. It may simply reflect an introverted preference for solitude, but when the avoidance is driven by anxiety, depression, or starts harming work, school, or relationships it can point to conditions such as social-anxiety disorder or depression and is worth discussing with a healthcare professional. People often say “asocial,” “reclusive,” or “solitary” for this pattern—just remember that “antisocial” is different and refers to violating others’ rights, not preferring to be alone.
The “3-3-3 rule” is a fast grounding trick: quietly name three things you can see, notice three sounds you can hear, then move or tense three different body parts (for example, wiggle toes, roll shoulders, stretch fingers). By shifting your senses and muscles to the here-and-now, it interrupts the mental spiral of “What are they thinking about me?” that fuels social anxiety. Use it as an on-the-spot reset, and seek longer-term help (like cognitive-behavioural therapy or medication) if anxiety is often limiting your life.
Social anxiety disorder is classified as an anxiety illness, not a neuro-developmental difference, so it isn’t considered “neurodivergent” in the way autism or ADHD are. Because up to half of autistic or ADHD individuals also meet criteria for social anxiety, the two often travel together, and people may describe their lived experience of both under the neurodivergence umbrella. If you deal with persistent social fear—especially alongside attention, sensory, or communication differences—ask a clinician to screen for both conditions so you can combine targeted therapy/medication for anxiety with neurodivergent-friendly supports and accommodations.
Cognitive restructuring for social anxiety follows a simple cycle: write down the anxious thought, ask Socratic questions (“What evidence do I have? How bad would it really be if it happened?”), and replace the thought with a more balanced view, then test that new belief in a small real-world “experiment” (e.g., speak up in a meeting and watch the recording to see how others actually react). Core tools that make this cycle easier are thought-record sheets, cost–benefit or decatastrophizing columns, evidence-for/against lists, and video or in-vivo experiments; used together and paired with gradual exposure—or with a CBT therapist if anxiety is severe—they consistently shrink the fear of negative evaluation.
The “new” medicine people are talking about is fasedienol (also called PH-94B), a nose-spray form of a neurosteroid that aims to calm the brain’s fear center within minutes; it is still in Phase-3 clinical trials, so doctors can’t prescribe it yet—access is only through research studies listed on ClinicalTrials.gov. Standard treatments like SSRIs (e.g., sertraline, paroxetine) and cognitive-behavioral therapy remain the go-to options, while other experimental drugs (such as BNC210 or MDMA-assisted therapy) are also under investigation. If you’re interested, ask your clinician about trial eligibility and continue proven therapies while the new medications work their way toward possible approval.
“7s anxiety” is not a recognized medical condition; people usually encounter this phrase when someone is talking about the GAD-7 questionnaire, where a score of 7 or higher can flag possible generalized anxiety disorder. If you or someone you know consistently feels excessive worry, restlessness, or physical symptoms (e.g., racing heart, trouble sleeping) that disrupt daily life, consider taking a validated screen like the GAD-7 and follow up with a licensed mental-health professional, as proven treatments such as cognitive-behavioral therapy, relaxation skills, and (when needed) medication can greatly reduce symptoms.
By Condition
By Location
By Subject
By Trial